Patents by Inventor Nanami Hashikura

Nanami Hashikura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Bifidobacterium Genus Bacterium
    Publication number: 20230066928
    Abstract: Novel Bifidobacterium bacteria having an opioid peptide decomposition action and a noncollagenous glycoprotein decomposition action are provided. The present invention relates to one or more kinds of Bifidobacterium bacteria selected from the group consisting of Bifidobacterium bifidum MCC1092 (NITE BP-02429), Bifidobacterium bifidum MCC1319 (NITE BP-02431), Bifidobacterium bifidum MCC1868 (NITE BP-02432), Bifidobacterium bifidum MCC1870 (NITE BP-02433), and Bifidobacterium longum subsp. longum MCC1110 (NITE BP-02430), as well as a composition for decomposing an opioid peptide and composition for decomposing a noncollagenous glycoprotein containing the Bifidobacterium bacteria as an active ingredient.
    Type: Application
    Filed: October 18, 2022
    Publication date: March 2, 2023
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Takuma Sakurai, Nanami Hashikura, Kanetada Shimizu, Sachiko Takahashi, Ayako Horigome
  • PREBIOTIC COMPOSITION FOR BUTYRIC ACID BACTERIA
    Publication number: 20220386667
    Abstract: An aspect is to provide a prebiotic for growing a butyrate-producing bacterium. A prebiotic composition for a butyrate-producing bacterium includes alginic acid and/or a salt thereof having an average molecular weight of 10000 or less.
    Type: Application
    Filed: June 26, 2020
    Publication date: December 8, 2022
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Toshitaka Odamaki, Ryuta Murakami, Nanami Hashikura
  • genus bacterium
    Patent number: 11504407
    Abstract: Novel Bifidobacterium bacteria having an opioid peptide decomposition action and a noncollagenous glycoprotein decomposition action are provided. The present invention relates to one or more kinds of Bifidobacterium bacteria selected from the group consisting of Bifidobacterium bifidum MCC1092 (NITE BP-02429), Bifidobacterium bifidum MCC1319 (NITE BP-02431), Bifidobacterium bifidum MCC1868 (NITE BP-02432), Bifidobacterium bifidum MCC1870 (NITE BP-02433), and Bifidobacterium longum subsp. longum MCC1110 (NITE BP-02430), as well as a composition for decomposing an opioid peptide and composition for decomposing a noncollagenous glycoprotein containing the Bifidobacterium bacteria as an active ingredient.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: November 22, 2022
    Assignee: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Takuma Sakurai, Nanami Hashikura, Kanetada Shimizu, Sachiko Takahashi, Ayako Horigome
  • Prebiotic Composition for Butyric Acid Bacteria
    Publication number: 20220054533
    Abstract: A problem is to provide a prebiotic which promotes the growth of a butyrate-producing bacterium. A prebiotic composition is described that promotes the growth of a butyrate-producing bacterium which contains alginic acid and/or a salt thereof.
    Type: Application
    Filed: January 6, 2020
    Publication date: February 24, 2022
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Toshitaka Odamaki, Nanami Hashikura, Ryuta Murakami, Eiko Yanagisawa
  • Composition for Degrading Opioid Peptide
    Publication number: 20210100853
    Abstract: An object of the present invention is to provide an agent for decomposing an opioid peptide or composition for decomposing an opioid peptide that does not restrict dietary habits, does not provide side reactions, even if it is daily used, and thus can be continuously used without any worries. The object is achieved by an agent for decomposing an opioid peptide or composition for decomposing an opioid peptide, pharmaceutical composition for decomposing an opioid peptide, or food or drink composition for decomposing an opioid peptide containing a Bifidobacterium bacterium, a culture of the bacterium, and/or a processed cell product of the bacterium as an active ingredient.
    Type: Application
    Filed: March 23, 2018
    Publication date: April 8, 2021
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Takuma Sakurai, Nanami Hashikura, Kanetada Shimizu, Akio Yamada
  • Novel Bifidobacterium Genus Bacterium
    Publication number: 20210100852
    Abstract: Novel Bifidobacterium bacteria having an opioid peptide decomposition action and a noncollagenous glycoprotein decomposition action are provided. The present invention relates to one or more kinds of Bifidobacterium bacteria selected from the group consisting of Bifidobacterium bifidum MCC1092 (NITE BP-02429), Bifidobacterium bifidum MCC1319 (NITE BP-02431), Bifidobacterium bifidum MCC1868 (NITE BP-02432), Bifidobacterium bifidum MCC1870 (NITE BP-02433), and Bifidobacterium longum subsp. longum MCC1110 (NITE BP-02430), as well as a composition for decomposing an opioid peptide and composition for decomposing a noncollagenous glycoprotein containing the Bifidobacterium bacteria as an active ingredient.
    Type: Application
    Filed: March 23, 2018
    Publication date: April 8, 2021
    Applicant: MORINAGA MILK INDUSTRY CO., LTD.
    Inventors: Takuma Sakurai, Nanami Hashikura, Kanetada Shimizu, Sachiko Takahashi, Ayako Horigome